BIO-TECHNE Corp Conversion of Stock, Shares Converted
BIO-TECHNE Corp (TECH) reported Conversion of Stock, Shares Converted of 309 shares for the 12-month period ending 2015-06-30, per its 10-K filed 2015-08-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2016-08-29
- BIO-TECHNE Corp conversion of stock, shares converted for fiscal 2015 was 309.00 shares, a 57.84% decline from fiscal 2014.
- BIO-TECHNE Corp conversion of stock, shares converted for fiscal 2014 was 733.00 shares.
- BIO-TECHNE Corp conversion of stock, shares converted for fiscal 2011 was 9.10K shares.
- BIO-TECHNE Corp conversion of stock, shares converted for fiscal 2009 was 348.00 shares.
| Period end | Conversion of Stock, Shares Converted 12 month |
|---|---|
| 2015-06-30 | 309.00 shares 10-K · filed 2015-08-31 |
| 2014-06-30 | 733.00 shares 10-K · filed 2016-08-29 |
| 2011-06-30 | 9.10K shares 10-K · filed 2013-08-29 |
| 2009-06-30 | 348.00 shares 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |